| pubmed-article:19473299 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19473299 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19473299 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
| pubmed-article:19473299 | lifeskim:mentions | umls-concept:C0043031 | lld:lifeskim |
| pubmed-article:19473299 | lifeskim:mentions | umls-concept:C0184661 | lld:lifeskim |
| pubmed-article:19473299 | lifeskim:mentions | umls-concept:C0547070 | lld:lifeskim |
| pubmed-article:19473299 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:19473299 | pubmed:dateCreated | 2009-9-7 | lld:pubmed |
| pubmed-article:19473299 | pubmed:abstractText | The recently published HRS/EHRA/ECAS AF Ablation Consensus Statement recommended that warfarin should be used for at least 2 months following an AF ablation in all patients regardless of stroke risk factors. The objective of the study was to assess outcomes based upon anticoagulation practice after atrial fibrillation (AF) ablation to determine relative risk of a strategy of aspirin only in low-risk patients. | lld:pubmed |
| pubmed-article:19473299 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19473299 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19473299 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19473299 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19473299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19473299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19473299 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19473299 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:19473299 | pubmed:issn | 1540-8167 | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:AndersonJeffr... | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:WeissJ... | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:BairTami LTL | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:BunchT... | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:LappeDonald... | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:MuhlesteinJ... | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:CrandallBrian... | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:FoleyThomasT | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:ScottAllisonA | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:NelsonJennife... | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:AndersonLarsL | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:DayJohn DJD | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:OsbornJeffrey... | lld:pubmed |
| pubmed-article:19473299 | pubmed:author | pubmed-author:MayHeidi THT | lld:pubmed |
| pubmed-article:19473299 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19473299 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:19473299 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19473299 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19473299 | pubmed:pagination | 988-93 | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:meshHeading | pubmed-meshheading:19473299... | lld:pubmed |
| pubmed-article:19473299 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19473299 | pubmed:articleTitle | Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures. | lld:pubmed |
| pubmed-article:19473299 | pubmed:affiliation | Intermountain Heart Rhythm Specialists, Intermountain Medical Center, Murray, Utah 84107, USA. Thomas.bunch@imail.org | lld:pubmed |
| pubmed-article:19473299 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19473299 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19473299 | lld:pubmed |
